Návratnosť kapitálu spoločnosti Telesis Bio Inc

Aká je hodnota metriky Návratnosť kapitálu spoločnosti Telesis Bio Inc?

Hodnota metriky Návratnosť kapitálu spoločnosti Telesis Bio Inc je -104.14%

Aká je definícia metriky Návratnosť kapitálu?



Return on capital employed (ROCE) je finančný ukazovateľ, ktorý meria rentabilitu spoločnosti a účinnosť spoločnosti vo využívaní vlastného kapitálu.

Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.

ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.

Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.

Návratnosť kapitálu spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Telesis Bio Inc

Čomu sa venuje spoločnosť Telesis Bio Inc?

sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.

Firmy s metrikou návratnosť kapitálu podobnou spoločnosti Telesis Bio Inc



  • Hodnota metriky Návratnosť kapitálu spoločnosti Smith Micro Software je -104.82%
  • Hodnota metriky Návratnosť kapitálu spoločnosti Acelrx Pharmaceuticals Inc je -104.62%
  • Hodnota metriky Návratnosť kapitálu spoločnosti Generic Gold je -104.39%
  • Hodnota metriky Návratnosť kapitálu spoločnosti Matinas Biopharma Inc je -104.27%
  • Hodnota metriky Návratnosť kapitálu spoločnosti Workhorse je -104.20%
  • Hodnota metriky Návratnosť kapitálu spoločnosti KOPR Point Ventures je -104.19%
  • Hodnota metriky Návratnosť kapitálu spoločnosti Telesis Bio Inc je -104.14%
  • Hodnota metriky Návratnosť kapitálu spoločnosti uBid je -103.91%
  • Hodnota metriky Návratnosť kapitálu spoločnosti CHF Solutions Inc je -103.66%
  • Hodnota metriky Návratnosť kapitálu spoločnosti Freeport Resources je -103.44%
  • Hodnota metriky Návratnosť kapitálu spoločnosti Serve Robotics Inc je -103.42%
  • Hodnota metriky Návratnosť kapitálu spoločnosti Tattooed Chef je -103.33%
  • Hodnota metriky Návratnosť kapitálu spoločnosti American Eagle Gold je -103.24%